Showing 1031-1040 of 3282 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20495/Letters to the Editor
https://practicaldermatology.com/topics/practice-management/letters-to-the-editor/20595/Color Me Healthy: Patient-Centered Care in Skin of Color
https://practicaldermatology.com/topics/skin-cancer-photoprotection/color-me-healthy-patient-centered-care-in-skin-of-color/20778/Dermatologists' approaches to treating darker skin types aren't color blind…yet.Top Developments in Vitiligo
https://practicaldermatology.com/topics/pigmentary-disorders/top-developments-in-vitiligo/67259/Vitiligo is no longer an afterthought in dermatology research.Selling Skin Care in Your Practice
https://practicaldermatology.com/topics/practice-management/selling-skin-care-in-your-practice/19294/While selling skin care products in your practice may seem like it has some disadvantages, Joel Schlessinger MD believes it's worth the extra work. During this video, Joel Schlessinger MD explains why he decided to sell products in his practice. Overall, he finds that selling items he recommends toINTEGUMENT-OLE and What’s Next for Pediatric AD
https://practicaldermatology.com/videos/skin-minute/integument-ole-study/56899/Pediatric dermatologist Larry Eichenfield, MD, talks about the INTEGUMENT-OLE study data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.Noah Worcester 2024: Dr. Gottlieb on Psoriatic Arthritis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gottlieb-psoriatic-arthritis/24594/Alice Gottlieb, MD, PhD, summarizes her lecture on the critical role of the dermatologist in preventing disability due to psoriatic arthritis at the 2024 Noah Worcester Dermatological Society meeting.Exosome Therapy: Explained
https://practicaldermatology.com/conferences/scale-2023/exosome-therapy-explained/20200/Jane Yoo, MD, explains exactly what exosomes are and highlights some current therapeutic uses for exosome therapy including treating hair loss and reducing redness after laser skin resurfacing.Finally: JAK Inhibitors Are Here
https://practicaldermatology.com/topics/psoriasis/finally-jak-inhibitors-are-here/20076/JAK inhibitors reach across all of dermatology, says Brett King, MD, PhD, who says the existing data is impressive and even more data are forthcoming for this class of medicine that will "change the landscape of dermatology."The Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.